Tuesday 18 September 2012

2nd Annual Market Access Oncology Forum, 16-17 October 2012, Spain

Accessing the market with a product value story With the government trying to cut down the costs on health spending, market access for oncology therapeutics is becoming more complicated and difficult. On the other hand, oncology medications, which are usually considered to be especially innovative, are increasing in demand. There is a need for industry, regulation and payers to find the best way of meeting demands on both sides and create a better and faster way of collaboration in order to meet the ultimale goal - patient access to innovative medications... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment